Current Trends in Therapeutics Research for Alzheimers Disease
Abstract
Kaushik Bharati
Recent trends in research for Alzheimer’s disease therapeutics are very promising. Currently, a multi-pronged approach is be- ing adopted and many novel strategies are being explored. The eventual goal is to reduce the symptoms by improving neuro- transmission in the brain, which slows down disease progres- sion. Scientists are trying to block β-amyloid plaque formation using monoclonal antibodies (mAbs) by harnessing the power of the immune system. This helps to prevent clumping of the neuro- fibrils constituting the plaques, as well as clearing the β-amyloid plaques from the brain. In the last couple of years, several mAbs, including aducanumab and lecanemab have been approved by the USFDA for treating Alzheimer’s disease.